Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$191.17 - $325.63 $4,205 - $7,163
22 Added 275.0%
30 $9,000
Q4 2023

Jan 31, 2024

SELL
$160.99 - $215.69 $22,860 - $30,627
-142 Reduced 94.67%
8 $1,000
Q3 2023

Oct 25, 2023

BUY
$194.33 - $283.97 $11,465 - $16,754
59 Added 64.84%
150 $29,000
Q2 2023

Jul 28, 2023

BUY
$223.05 - $302.68 $446 - $605
2 Added 2.25%
91 $25,000
Q1 2023

Apr 26, 2023

SELL
$175.41 - $217.92 $2,631 - $3,268
-15 Reduced 14.42%
89 $19,000
Q4 2022

Jan 24, 2023

SELL
$204.38 - $296.82 $18,598 - $27,010
-91 Reduced 46.67%
104 $0
Q3 2022

Nov 10, 2022

BUY
$195.21 - $310.53 $9,955 - $15,837
51 Added 35.42%
195 $54,000
Q2 2022

Aug 01, 2022

BUY
$115.91 - $214.48 $5,331 - $9,866
46 Added 46.94%
144 $28,000
Q1 2022

Apr 21, 2022

BUY
$127.96 - $207.36 $12,028 - $19,491
94 Added 2350.0%
98 $20,000
Q2 2021

Jul 27, 2021

BUY
$131.45 - $201.49 $525 - $805
4 New
4 $1,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.